News
- Author:
- Jessica Craig
Publish date: June 27, 2016
Key clinical point: The addition of radiotherapy (RT) to androgen deprivation therapy (ADT) was associated with improved survival in men with pros...
News
- Author:
- Jessica Craig
Publish date: June 21, 2016
News
- Author:
- Jessica Craig
Publish date: June 20, 2016
Key clinical point: Telephone genetic counseling was noninferior to in-person counseling for women at increased risk of hereditary breast and/or o...
News
- Author:
- Jessica Craig
Publish date: June 19, 2016
Key clinical point: Overall response rates ranged from 30% to 71% when pembrolizumab was added to chemotherapy combinations or paired with an R2 i...
News
- Author:
- Jessica Craig
Publish date: June 16, 2016
Key clinical point: Pembrolizumab is superior to docetaxel in patients with non–small cell lung cancer especially at higher TPS. PD-L1 may b...
News
- Author:
- Jessica Craig
Publish date: June 16, 2016
Key clinical point: Results of a small randomized trial and an analysis of the National Cancer Data Base show conflicting results about the benefi...
News
- Author:
- Jessica Craig
Publish date: June 16, 2016
Key clinical point: A heat shock protein peptide vaccine appears safe and effective for patients with glioblastoma in an early stage trial.
Major ...
News
- Author:
- Jessica Craig
Publish date: June 15, 2016
Key clinical point: Neoadjuvant chemotherapy alters the immune microenvironment in patients with advanced ovarian cancer. Major finding: Neoadjuvan...
News
- Author:
- Jessica Craig
Publish date: June 10, 2016
Key clinical point: Vandetanib shows marked yet variable anti-tumor activity and toxicity in patients with RET-rearranged NSCLC.
Major finding: Th...
News
- Author:
- Jessica Craig
Publish date: June 9, 2016
Key clinical point: Taking into account a country’s wealth and cost of living, cancer drugs are most affordable in Australia, least affordab...
News
- Author:
- Jessica Craig
Publish date: June 8, 2016
Key clinical point: Rova-T is active in DLL3-expressing recurrent and refractory small–cell lung cancer.
Major finding: The clinical benefit...
Video
- Author:
- Jessica Craig
Publish date: June 7, 2016
Video
- Author:
- Jessica Craig
Publish date: June 4, 2016
News
- Author:
- Jessica Craig
Publish date: June 4, 2016
Key clinical point: MYL-1401O is comparable in safety and efficacy to trastuzumab for women with HER2-positive advanced breast cancer.
Major findi...
News
- Author:
- Jessica Craig
Publish date: June 1, 2016
Key clinical point: A phase I trial indicates that Toca 511 is safe and shows activity in treating patients with high-grade or recurrent glioblast...
